The article discusses the recent FDA approval of the first drug that addresses the root cause of narcolepsy, which could potentially pave the way for new treatments for various sleep disorders. It notes that while existing medications primarily alleviate symptoms like excessive daytime sleepiness, this new drug aims to target the underlying issues, potentially improving outcomes for a broader range of sleep-related conditions.

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

https://www.wsj.com/health/pharma/the-race-to-come-up-with-the-next-big-sleep-drug-473a4a5e

The Race to Come Up With the Next Big Sleep Drug

FDA approves first drug to treat a root cause of narcolepsy, which could help other sleep conditions as well

Xavier Martinez

Comments Button

Listen

(1 min)

A student asleep with their head on a desk next to a laptop. Around 60,000 people in the U.S. have been diagnosed with narcolepsy. Getty Images

Narcolepsy isn’t easy to treat. Existing drugs manage patients’ symptoms—notably excessive daytime sleepiness and difficulty sleeping at night—rather than the cause. Yet a new type of drug is emerging that targets the root of the disorder.

It might lead to better drugs for a whole range of sleep problems.

The Race to Come Up With the Next Big Sleep Drug

The Race to Come Up With the Next Big Sleep Drug

FDA approves first drug to treat a root cause of narcolepsy, which could help other sleep conditions as well

Videos

Most Popular News

Most Popular

Recommended Videos